Literature DB >> 12053395

Critical pulmonary stenosis.

L A Latson1.   

Abstract

Critical pulmonary stenosis causes cyanosis and can be potentially lethal in the neonate. Initial treatment includes general resuscitation and infusion of prostaglandin E1 to dilate the ductus. The diagnosis is usually made echocardiographically, but a right ventriculogram in the outflow tract may be necessary in some patients with only a tiny valve opening. Preformed catheters may aid in the passage of an appropriate guidewire. Valvuloplasty should be performed with a balloon approximately 1.2 times the annulus diameter. Most patients remain mildly to moderately cyanotic immediately after the procedure. With right ventricular (RV) growth and improved RV compliance, the cyanosis eventually resolves. Some patients may require prolonged prostaglandin infusion, a surgical shunt, or other mechanical means of maintaining systemic-to-pulmonary artery flow. Intermediate--to long-term results are excellent. However, only 5%-10% of patients may require surgical relief of residual valve or subvalvular stenosis. Very long-term follow-up raises concern about the significance of induced pulmonary insufficiency. Up to 30% of patients may require repeat balloon valvuloplasty.

Entities:  

Mesh:

Year:  2001        PMID: 12053395     DOI: 10.1111/j.1540-8183.2001.tb00343.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  3 in total

1.  Intervention in Patients with Critical Pulmonary Stenosis in the Ductal Stenting Era.

Authors:  Ilker Kemal Yucel; Mustafa Orhan Bulut; Mehmet Kucuk; Sevket Balli; Ahmet Celebi
Journal:  Pediatr Cardiol       Date:  2016-03-31       Impact factor: 1.655

2.  Delayed Amplatzer device closure of atrial septal defect for persistent cyanosis after surgical correction of severe pulmonary stenosis in early infancy.

Authors:  A Falzon; V Grech; Jv Degiovanni
Journal:  Images Paediatr Cardiol       Date:  2004-01

3.  Serum N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Critical Pulmonary Stenosis in Neonates.

Authors:  Zhiwei Lin; Yanru Chen; Lin Zhou; Sun Chen; Hongping Xia
Journal:  Front Pediatr       Date:  2022-01-05       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.